Article
The Host-Microbiome Response to Hyperbaric Oxygen Therapy in Ulcerative Colitis Patients
1 Jan 2022
Abstract excerpt
Background & Aims Hyperbaric oxygen therapy (HBOT) is a promising treatment for moderate-to-severe ulcerative colitis. However, our current understanding of the host and microbial response to HBOT remains unclear. This study examined the molecular mechanisms underpinning HBOT using a multi-omic strategy. Methods Pre- and post-intervention mucosal biopsies, tissue, and fecal samples were collected from HBOT phase...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
